Literature DB >> 5570677

The immunopathological significance of the heterogeneity of antibody affinity.

J F Soothill, M W Steward.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5570677      PMCID： PMC1713022     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  13 in total

1.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

2.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

3.  Genetic control of the specificity of anti-DNP antibodies. II. Differences in the specificity of anti-DNP antibody produced by several inbred strains of mice.

Authors:  W E Paul; T Yoshida; B Benacerraf
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

4.  Chronic granulomatous disease: quantitative clinicopathological relationships.

Authors:  E N Thompson; J F Soothill
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

5.  Experimental chronic glomerulitis.

Authors:  T Pincus; R Haberkern; C L Christian
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

Review 6.  The immune response to a simple antigenic determinant.

Authors:  H N Eisen
Journal:  Harvey Lect       Date:  1966

7.  Character of non-precipitating antibodies.

Authors:  C L Christian
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

8.  The estimation of the concentration and equilibrium constant of anti-D.

Authors:  N C Hughes-Jones
Journal:  Immunology       Date:  1967-05       Impact factor: 7.397

9.  Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors:  F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

10.  Antihapten antibody specificity and L chain type.

Authors:  V Nussenzweig; B Benacerraf
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307
View more
  65 in total

1.  The genetic control of antibody affinity in mice.

Authors:  F E Katz; M W Steward
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

2.  Determination of anti-ds-DNA antibodies by three different methods: comparison of sensitivity, specificity and correlation with lupus activity index (LAI).

Authors:  A G Tzioufas; C Terzoglou; E D Stavropoulos; S Athanasiadou; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

3.  Chronic immune complex disease in mice: the role of antibody affinity.

Authors:  M W Steward
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

Review 4.  Antibody affinity: immunogenetic aspects and relationship to immune complex disease.

Authors:  M W Steward
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

Review 5.  Therapeutic aspects. Immunosuppression in established humoral responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

6.  Relationship of antibody affinity to onset of immune complex disease in New Zealand mice.

Authors:  R E Petty; M W Steward
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

7.  Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; M Leirisalo; E Johansson; G Gripenberg
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

8.  Evidence for the genetic control of antibody affinity from breeding studies with inbred mouse strains producing high and low affinity antibody.

Authors:  M W Steward; R E Petty
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

9.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

10.  DNA binding activity of serum from patients with systemic lupus erythematosus.

Authors:  J F Halsey; W A Woolery; S Oleinick; M B Kahaleh; E C Leroy
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.